Molecular LogiX is a drug discovery company. The objective of the Company is to create new drug leads to address the un-met clinical need for effective “molecular targeting” agents to treat human diseases.
The Company is developing a new class of anti-cancer therapeutics that will be the first in a series of new, powerful protein-based products. We capitalize on our capabilities in protein engineering and cellular biology to make subtle, rational changes in known proteins, to create valuable new therapeutics. We work closely with our academic and industrial collaborators to minimize the time and expense of moving our drug leads from “the bench to the bedside.”